Why Do Early-Onset FSHD Patients Need Eye & Hearing Exams?
At a Glance
Early-onset FSHD can affect blood vessels in the retina and sensory nerves in the inner ear, leading to silent vision damage and high-frequency hearing loss. Routine dilated eye exams and audiometry are essential to catch these issues early and protect a child's development.
When a child is diagnosed with early-onset (also called infantile) Facioscapulohumeral muscular dystrophy (FSHD), discovering that they need frequent, specialized eye and hearing exams can feel overwhelming. However, these proactive screenings are a powerful way to protect your child’s development and well-being. The genetic changes that cause early-onset FSHD—specifically, very short D4Z4 repeats (usually 1 to 3 repeats)—affect more than just skeletal muscles [1]. In these early-onset cases, the disease can also impact the blood vessels in the retina and the sensory nerves in the inner ear [2][3]. Frequent screening is essential because these changes often show no obvious symptoms early on, but they are highly manageable when caught quickly [4].
The Link Between FSHD, Eyes, and Ears
FSHD is caused by the abnormal activation of a gene called DUX4, which is normally turned off in most of the body’s cells [5]. In patients with early-onset FSHD, a larger portion of genetic material is missing (fewer D4Z4 repeats), which allows the DUX4 gene to become highly active and cause more severe disease [5][1]. While this primarily causes progressive muscle weakness, the systemic effects of the disease can also damage fragile cells in the eyes and ears [6].
Protecting Vision: Exudative Retinopathy
Children with early-onset FSHD and large genetic deletions have a higher risk of developing leaky blood vessels in the eye, a condition called exudative retinopathy (which closely resembles Coats’ disease) [4][7].
- What happens: Abnormal blood vessels grow in the retina (the light-sensitive tissue at the back of the eye) and begin to leak fluid or blood [4].
- The risk: If left undetected for too long, this fluid buildup can lead to retinal scarring and permanent vision loss [4].
- Why screening matters: Exudative retinopathy is often completely silent in its early stages [4]. A specialized test called a dilated indirect ophthalmoscopy allows a pediatric eye doctor to look deep into the retina and spot these leaking vessels before they cause damage.
- What treatment looks like: If caught early, these abnormal vessels can be successfully treated with minimally invasive procedures like laser therapy or cryotherapy (freezing) to seal the leaks and preserve the child’s vision [4].
- What to expect during the exam: The doctor will use eye drops to widen (dilate) your child’s pupils. While the drops might sting briefly and make their eyes sensitive to light for a few hours, the exam itself is painless. For very young or squirmy children, pediatric eye specialists are trained to make the process as quick and distraction-filled as possible.
Protecting Hearing and Development: Sensorineural Hearing Loss
Hearing changes are another well-documented complication of early-onset FSHD [8].
- What happens: Children can develop sensorineural hearing loss, meaning the issue lies in the inner ear or the nerve pathways [9]. In FSHD, this typically affects the ability to hear high-frequency (high-pitched) sounds first [4].
- The risk: Because a child might still hear lower pitches clearly, high-frequency hearing loss is easy to miss at home. If undetected, missing these sounds can interfere with speech milestones and language development [4].
- Why screening matters: Routine audiometry (hearing tests) can detect these specific high-pitch deficits early [4]. Early detection is incredibly empowering—it allows your care team to promptly introduce interventions like hearing aids or speech therapy, ensuring your child’s language development and learning stay right on track [4].
Recommended Screening Guidelines
To protect your child during their most critical developmental windows, consensus guidelines from organizations like the American Academy of Neurology (AAN) emphasize proactive monitoring for early-onset patients [4]:
- At Diagnosis: A comprehensive baseline audiometry test and a dilated indirect ophthalmoscopy should be performed as soon as the child is diagnosed [4].
- Ongoing Monitoring: Annual follow-up screenings are highly recommended, particularly for children with the shortest D4Z4 repeat lengths (1-3) [4]. Regular monitoring ensures that any changes to their vision or hearing are caught and addressed immediately as they grow [4].
Common questions in this guide
Why does early-onset FSHD affect the eyes and ears?
What is exudative retinopathy in children with FSHD?
What kind of hearing loss is associated with early-onset FSHD?
How often should a child with early-onset FSHD have eye and hearing exams?
Related questions
Get notified when new evidence is published on Facioscapulohumeral dystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (9)
- 1
FSHD1 Diagnosis in a Russian Population Using a qPCR-Based Approach.
Zernov NV, Guskova AA, Skoblov MY
Diagnostics (Basel, Switzerland) 2021; (11(6)) doi:10.3390/diagnostics11060982.
PMID: 34071558 - 2
Early onset facioscapulohumeral dystrophy - a systematic review using individual patient data.
Goselink RJM, Voermans NC, Okkersen K, et al.
Neuromuscular disorders : NMD 2017; (27(12)):1077-1083 doi:10.1016/j.nmd.2017.09.007.
PMID: 29102079 - 3
Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy.
Goselink RJM, Mul K, van Kernebeek CR, et al.
Neurology 2019; (92(4)):e378-e385 doi:10.1212/WNL.0000000000006819.
PMID: 30568007 - 4
Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine.
Tawil R, Kissel JT, Heatwole C, et al.
Neurology 2015; (85(4)):357-64 doi:10.1212/WNL.0000000000001783.
PMID: 26215877 - 5
Inflammatory facioscapulohumeral muscular dystrophy type 2 in 18p deletion syndrome.
Renard D, Taieb G, Garibaldi M, et al.
American journal of medical genetics. Part A 2018; (176(8)):1760-1763 doi:10.1002/ajmg.a.38843.
PMID: 30055030 - 6
Systemic manifestations and symptom burden of facioscapulohumeral muscular dystrophy in a referral cohort.
Kelly CR, Saw JL, Thapa P, et al.
Muscle & nerve 2022; (65(4)):415-421 doi:10.1002/mus.27493.
PMID: 35020192 - 7
Coats-like Retinopathy Associated With 18p Deletion Syndrome.
Williams JE, Recchia FM
Ophthalmic surgery, lasers & imaging retina 2025; (56(10)):629-632 doi:10.3928/23258160-20250718-02.
PMID: 40788857 - 8
Hearing Loss, Retinal Abnormality, and Seizures in People With Facioscapulohumeral Muscular Dystrophy.
Kilburn SN, Thomas S, Havlik AL, et al.
Muscle & nerve 2025; (72(5)):1156-1160 doi:10.1002/mus.70007.
PMID: 40879179 - 9
GGPS1 Mutations Cause Muscular Dystrophy/Hearing Loss/Ovarian Insufficiency Syndrome.
Foley AR, Zou Y, Dunford JE, et al.
Annals of neurology 2020; (88(2)):332-347 doi:10.1002/ana.25772.
PMID: 32403198
This page provides educational information about screening guidelines for early-onset FSHD. Always consult your pediatric neurologist, ophthalmologist, and audiologist for personalized medical advice and screening schedules.